Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by canadafanon Jan 05, 2021 2:48pm
363 Views
Post# 32225473

RE:Its nice to hear 8.50 share price

RE:Its nice to hear 8.50 share priceirishwolfhond;
Your comments are uninfomred, short sighted and showinig a nievity needing information.
So Ill start.

First the day-day price 'cant get above $3.00" look at the trend & chart,Withinkast 3- 5 years has been well above the $8.50 mentioned. 
Just 12 months ago above $6.25

Next the "analysts" who put the valuations forward. they do-so based on in-depth review of all potential oppotunies of the company.
Presenly ONC is in trials with Pfizer, Roche, B.M.S. Incyte & Merck
All of which have done their own in-depth DD prior to the co-devlopment agreements/trials & studies.
Now.....should anyone of the 3 major studies ( some rsutls due next few months) prove, a good match.
Then a "partenrship" deal will be done to move Pela into Phase3 breast cancer trials.
Or any one of the other 3 types of cancer they are working on. Roche for example is looking at 2 separate types.
Why does today's price not matter? 
If the science proves out ( and all indictions so far have been positive) , a $$$ deal will be done & the price of ONC will be mutiples of today.
The $8.50 ( average of analysts) is based on projections one year out, with lots of conservative factors.
The Canadian analysts adds an up-side of $18Ps shuld they ink a prtnership or firm up trial results.
Alternalty should the science fail, the company is not worth much.
It is that risk & the trial time involved that holds the price back.
( not to mention. short sighted day traders). 
When will the price to $8.50 take place??? Check out GLSI another bio-tech
Was trading low $2-$3 range for longest time. Came out with some positive news. 
Price went to $120Ps++ in one day!
Granted it has settled back to mid $35 range. 
That news BTW not even close to what ONC has the capability of.
NO BS, you could have bought GLSI a few days before the news for under $5. moring of news. Premarket was mid $30s: By noon over $100.
Never never underestimate the potential upside of a biotech
If even one of the 3 trials ONC is involved in says the right words. You wont even be able to get an order in. market price only and well above the $8.50 
Look around go to ONC sight get educated.
GLSI had sucsess with a phase2 , very limited application. ONC has a much broader base application of the productT
that is is what is slowing thinsg down.They are proving out the wide base theory.






<< Previous
Bullboard Posts
Next >>